Pacer Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Pacer Advisors, Inc.
- $34.2 Billion
- Q2 2025
A detailed history of Pacer Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 734,579 shares of JAZZ stock, worth $83.2 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
734,579
Previous 844,705
13.04%
Holding current value
$83.2 Million
Previous $105 Million
25.67%
% of portfolio
0.23%
Previous 0.3%
Shares
18 transactions
Others Institutions Holding JAZZ
# of Institutions
557Shares Held
62.7MCall Options Held
559KPut Options Held
74.5K-
Black Rock Inc. New York, NY6.15MShares$696 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$690 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$289 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$288 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$288 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.1B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...